Our findings underscore the importance of Th2-mediated responses in regulating hepatic ACE levels, highlighting a potentially novel aspect of RAS modulation in patients with obesity and MASLD. The gene discussed is ACE; the disease is obesity due to melanocortin 4 receptor deficiency.